New studies find Omicron COVID boosters no better than original, contradicting feds’ messaging
Researchers suspect “immune imprinting” is responsible. Less than two months after the FDA used mouse data to give emergency use authorization to bivalent COVID-19 boosters, the real-world performance of the shots that target the ancestral strain and Omicron BA.4/5 subvariants is undermining the feds’ one-size-fits-all messaging. New preprint studies by researchers at Columbia University and Beth Israel Deaconness Medical Center, … Read more